Is manganese an essential supplement for parenteral nutrition?

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 11, Issue 3, 2008, Pages 289-296

  Hardy, Ines J ^a   Gillanders, Lyn ^b   Hardy, Gil ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

Home parenteral nutrition; Manganese; Paediatric; Trace elements

Indexed keywords

MANGANESE; TRACE METAL;

BLOOD ANALYSIS; DIET SUPPLEMENTATION; GASTROINTESTINAL TRACT FUNCTION; HOMEOSTASIS; HUMAN; HYPERMANGANESEMIA; LIVER FUNCTION TEST; LONG TERM CARE; MANGANESE ABSORPTION; MANGANESE DEFICIENCY; MANGANESE DISTRIBUTION; MANGANESE ELIMINATION; MANGANESE TOXICITY; METABOLIC DISORDER; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUTRITIONAL DEFICIENCY; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; PHARMACOKINETICS; REVIEW; TOXICITY;

ADOLESCENT; ADULT; CHILD; DIETARY SUPPLEMENTS; FEMALE; HUMANS; INFANT, NEWBORN; LONG-TERM CARE; MALE; MANGANESE; MANGANESE POISONING; PARENTERAL NUTRITION; PRACTICE GUIDELINES AS TOPIC; TIME FACTORS;

EID: 42149171795     PISSN: 13631950     EISSN: 15353885     Source Type: Journal    
DOI: 10.1097/MCO.0b013e3282f9e889     Document Type: Review

References (53)

1. Ascher JL, Ascher M. Nutritional aspects of manganese homeostasis. Mol Aspects Med 2005; 26:353-362.
2. Pennington JA, Shoen SA. The total diet study: estimated dietary intakes of nutritional elements 1982-1991. Int J Vitam Nutr Res 1996; 66:350-363.
3. Messing B, Joly F. Guidelines for management of home parenteral support in adult chronic intestinal failure patients. Gastroenterology 2006; 130:s43-s51.
4. Siepler JK, Nishikawa RA, Diamantidis T, et al. Asymptomatic hypermanganesemia in long-term home parenteral nutrition patients. Nutr Clin Prac 2003; 18:370-373.
5. Dickerson RN. Manganese intoxication and parenteral nutrition. Nutrition 2001; 17:689-693.
6. Hardy G, Campos A. Nutrition without frontiers: time for a standardization in clinical nutrition. Curr Opin Clin Nutr Metab Care 2004; 7:279-283.
7. McKinney AM, Filice RW, Teksam M, et al. Diffusion abnormalities of the globi pallidi in manganese neurotoxicity. Neuroradiology 2004; 46:291-295.
8. Dobson AW, Erikson KM, Aschner M. Manganese Neurotoxicity. Ann NY Acad Sci 2004; 1012:115-128.
9. Takeda A. Manganese action in brain function. Brain Res Rev 2003; 41:79-87.
10. Fitsanakis VA, Zhang N, Avison MJ, et al. The use of magnetic resonance imaging (MRI) in the study of manganese neurotoxicity. Neurotoxicology 2006; 27:789-806.
11. Klos KJ, Chandler M, Kumar N, et al. Neuropsychological profiles of manganese neurotoxicity. Eur J Neurol 2006; 13:1139-1141.
12. Van Gossum A, Neve J. Trace element deficiency and toxicity. Curr Opin Clin Nutr Metab Care 1998; 1:499-507.
13. Herrero-Hernandez E, Valentini MC, Discalzi G. T1-weighted hyperintensity in basal ganglia at brain magnetic resonance imaging: are different pathologies sharing a common mechanism. Neurotoxicology 2002; 23:669-674.
14. Finley JW, Davis CD. Manganese deficiency and toxicity: are high or low dietary amounts of manganese cause for concern? Bio Factors 1999; 10:15-24.
15. Salvino R, Ghanta R, Seidner DL, et al. Liver failure is uncommon in adults receiving long-term parenteral nutrition. JPEN 2006; 30:202-208.
16. Matsumoto K, Suita S, Taguchi T, et al. Manganese intoxication during intermittent parenteral nutrition: report of two cases. JPEN 2001; 25:95-99.
17. Fok TF, Chui KKM, Cheung R, et al. Manganese intake and cholestatic jaundice in neonates receiving parenteral nutrition: a randomized controlled study. Acta Paediatr 2001; 90:1009-1015.
18. Takagi Y, Okada A, Sando K, et al. On-off study of manganese administration to adult patients undergoing home parenteral nutrition: new indices of in vivo manganese level. JPEN 2001; 25:87-92.
19. Iinuma Y, Kubota M, Uchiyama M, et al. Whole-blood manganese levels and brain manganese accumulation in children receiving long-term home parenteral nutrition. Pediatr Surg Int 2003; 19:268-272.
20. O'Donnell K, Radigan A. Hypermanganesemia in an acute care setting. Nutr Clin Prac 2003; 18:374-376.
21. Ali A, Murdoch A, Pascoe A, et al. Hypermanganesemia observed in patients receiving home parenteral nutrition (PN) with or without cholestasis. In: Poster Presentation at the 2006 AuSPEN Conference; 9-11 November 2006; Sydney, Australia.
22. Howard L, Ashley C, Lyon D, et al. Autopsy tissue trace elements in 8 longterm parenteral nutrition patients who received the current US Food and Drug Administration formulation. JPEN 2007; 31:388-396. A novel investigation into the cumulative effects of trace element supplementation on autopsy tissues that challenges routine incorporation of manganese in parenteral nutrition (PN).
23. Hsieh CT, Liang JS, Peng SSH, et al. Seizure associated with total parenteral nutrition-related hypermanganesemia. Paediatr Neurol 2007; 36:181-183. A recent case report that demonstrates the neurological dangers of intravenous manganese supplementation at currently recommended levels.
24. Hambridge KM, Sokol RJ, Fidanza SJ, et al. Plasma manganese concentrations in infants and children receiving parenteral nutrition. JPEN 1989; 13:168-171.
25. Reynolds N, Blumsohn A, Baxter JP, et al. Manganese requirement and toxicity in patients on home parenteral nutrition. Clin Nutr 1998; 17:227-230.
26. Reimund JM, Dietemann JL, Warter JM, et al. Factors associated to hypermanganesemia in patients receiving home parenteral nutrition. Clin Nutr 2000; 19:343-348.
27. Fuhrman PM. Micronutrient assessment in long-termhome parenteral nutrition patients. Nutr Clin Prac 2006; 21:566-575.
28. Malecki EA, Lo HC, Yang H, et al. Tissue manganese concentrations and antioxidant enzyme activity in rats given total parenteral nutrition with and without supplemental manganese. JPEN 1995; 19:222-226.
29. Greger JL. Dietary standards for manganese: overlap between nutritional and toxicological studies. J Nutr 1998; 128:386S-371S.
30. Alves G, Thiebot J, Tracqui A, et al. Neurologic disorders due to brain manganese deposition in a jaundiced patient receiving long-term parenteral nutrition. JPEN 1997; 21:41.
31. Barceloux DG. Manganese. Clin Toxicol 1999; 37:293-307.
32. Takagi Y, Okada A, Sando K, et al. Evaluation of indexes of in vivo manganese status and the optimal intravenous dose for adult patients undergoing home parenteral nutrition. Am J Clin Nutr 2002; 75:112-118.
33. Tietz NW, editor. Textbook of clinical chemistry. 3rd ed. Philadelphia: WB Saunders; 1998.
34. Wardle CA, Forbes A, Roberts NB, et al. Hypermanganesemia in long-term intravenous nutrition and chronic liver disease. JPEN 1999; 23:350-355.
35. Freeland-Graves J, Llanes C. Models to study manganese deficiency. In: Klimis-Tavantzis DJ, editor. Manganese in Health and Disease. Boca Raton, Fl: CRC Press; 1994. pp. 115-120.
36. Keen CL, Ensunsa JL, Watson MH, et al. Nutritional aspects of manganese from experimental studies. Neurotoxicology 1999; 20:213-223.
37. Bertinet DB, Trinivella M, Balzola FA, et al. Brain manganese deposition and blood levels in patients undergoing home parenteral nutrition. JPEN 2000; 24:223-227.
38. Friedman BJ, Freeland-Graves JH, Bales CW, et al. Manganese balance and clinical observations in young men fed a manganese deficient diet. J Nutr 1987; 117:133-143.
39. Penland JG, Johnson PE. Dietary Calcium and manganese effects on menstrual cycle symptoms. Am J Obstet Gynecol 1993; 168:1417-1423.
40. Norose N, Terai M, Norose K. Manganese deficiency in a child with very short bowel syndrome receiving long-term parenteral nutrition. J Trace Elem Exp Med 1992; 5:100.
41. Bozzetti F, Straun, M, Van Gossum A, editors. Home Parenteral Nutrition. Wallingford: Cabi Press, UK; 2006.
42. Angstmann K, Ball P, Hardy G, et al. AuSPEN HPN Register 2007 Annual Report. www.auspen.org.au.
43. Kurkus J, Alcock NW, Shiles ME. Manganese content of large volume parenteral solutions and of nutrient additives. JPEN 1984; 8:254-257.
44. Buchman AL, Neely M, Grossie VB Jr, et al. Organ heavy-metal accumulation during parenteral nutrition is associated with pathologic abnormalities in rats. Nutrition 2001; 17:600-606.
45. Ocaña M & Hardy G. Trace element contamination of some home parenteral nutrition solutions. Poster Presentation at the 2006 AuSPEN Conference, Sydney Australia.
46. National Academy of Sciences (NAS). Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Panel on Micronutrient, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Use of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. 2001; Available from: www.nap.edu/books/0309072794/html/.
47. Australian Government, Department of Health and Ageing, National Health and Medical Research Council. Nutrient Reference Values for Australia and New Zealand. July 2006.
48. American Medical Association Department of Foods and Nutrition. Guidelines for essential trace element preparations for parenteral use. A statement by an expert panel. JAMA 1979; 241: 2051-2054.
49. Russell D. The Australasian Society for Parenteral and Enteral Nutrition (AuSPEN) Guidelines for intravenous trace elements and vitamins. May 1999.
50. Mirtallo J, Canada T, Johnson D, et al. Safe practices for parenteral nutrition. JPEN 2004; 28:S39-S70.
51. Koletzko B, Goulet O, Krohn K, et al. Guidelines on paediatric parenteral nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPHGAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), supported by the European Society of Paediatric Research (ESPR). J Paediatr Gastroenterol Nutr 2005; 41:S1-S87.
52. Khoo C, Spencer A, Hardy G. Provision of manganese and other trace elements for parenteral nutrition. Asia Pac J Clin Nutr 2007; 16 (Suppl 3): S95.
53. Food and Drug Administration. Aluminum in large and small volume parenterals used in total parenteral nutrition. Fed Regist 2000; 6:4103-4111.